There is currently no cure for HD progression, but advances in oligonucleotide therapeutics have put effective treatments within reach.51–57 ASOs that block expression of HTT mRNA by inducing nuclear RNA degradation through ribonuclease H1 are in the clinic.56 Here, RNASEH1 is linked to Huntington disease.